Cargando…
Predictive Power of MIB-1 vs. Mitotic Count on Progression-Free Survival in Skull-Base Meningioma
SIMPLE SUMMARY: Meningiomas are mainly benign intracranial tumors. Nevertheless, risk of recurrence exists in long-term follow-up, so new prognostic markers are still need to be identified. MIB-1 is no diagnostic criterion in WHO classification of meningiomas by now. This retrospective study shows t...
Autores principales: | Lampmann, Tim, Wach, Johannes, Schmitz, Marie-Therese, Güresir, Ági, Vatter, Hartmut, Güresir, Erdem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561976/ https://www.ncbi.nlm.nih.gov/pubmed/36230518 http://dx.doi.org/10.3390/cancers14194597 |
Ejemplares similares
-
FORGE: A Novel Scoring System to Predict the MIB-1 Labeling Index in Intracranial Meningiomas
por: Wach, Johannes, et al.
Publicado: (2021) -
MAC-spinal meningioma score: A proposal for a quick-to-use scoring sheet of the MIB-1 index in sporadic spinal meningiomas
por: Wach, Johannes, et al.
Publicado: (2022) -
Increased MIB-1 Labeling Index Is Associated with Abducens Nerve Morbidity in Primary Sporadic Petroclival Meningioma Surgery: Beyond Location and Approach
por: Wach, Johannes, et al.
Publicado: (2022) -
The impact of the MIB-1 index on facial nerve outcomes in vestibular schwannoma surgery
por: Wach, Johannes, et al.
Publicado: (2020) -
Proliferative Potential, and Inflammatory Tumor Microenvironment in Meningioma Correlate with Neurological Function at Presentation and Anatomical Location—From Convexity to Skull Base and Spine
por: Wach, Johannes, et al.
Publicado: (2022)